Drug Shortage Report for DEXAMETHASONE-OMEGA
| Report ID | 272781 |
| Drug Identification Number | 02204266 |
| Brand name | DEXAMETHASONE-OMEGA |
| Common or Proper name | Dexamethasone Sodium Phosphate Injection USP 4 mg/mL |
| Company Name | OMEGA LABORATORIES LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXAMETHASONE PHOSPHATE |
| Strength(s) | 4MG |
| Dosage form(s) | LIQUID |
| Route of administration | SOFT TISSUE INJECTION INTRAVENOUS INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR SOFT TISSUE INJECTION INTRAVENOUS INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR |
| Packaging size | 5 x 5mL vial / fiole |
| ATC code | H02AB |
| ATC description | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-11-26 |
| Estimated end date | 2026-01-15 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-11-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
| Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2025-11-27 | French | Compare |
| v2 | 2025-11-27 | English | Compare |
| v1 | 2025-11-27 | English | Compare |
Showing 1 to 3 of 3